Compile Data Set for Download or QSAR
maximum 50k data
Found 32 of ec50 data for polymerid = 5492
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287989(US10087167, Compound 3003)
Affinity DataEC50:  25.2nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288003(US10087167, Compound 4012)
Affinity DataEC50:  27.1nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288011(US10087167, Compound 4020)
Affinity DataEC50:  45nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287983(US10087167, Compound 1001)
Affinity DataEC50:  45.4nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288015(US10087167, Compound 4024)
Affinity DataEC50:  76.5nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288007(US10087167, Compound 4016)
Affinity DataEC50:  84.8nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287998(US10087167, Compound 4007)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287995(US10087167, Compound 4005)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287992(US10087167, Compound 4003)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287991(US10087167, Compound 4002)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287988(US10087167, Compound 3002)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287986(US10087167, Compound 3001)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288002(US10087167, Compound 4011)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288017(US10087167, Compound 4026)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288016(US10087167, Compound 4025)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288014(US10087167, Compound 4023)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288013(US10087167, Compound 4022)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288006(US10087167, Compound 4015)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288005(US10087167, Compound 4014)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288004(US10087167, Compound 4013)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288001(US10087167, Compound 4010)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288000(US10087167, Compound 4009)
Affinity DataEC50: <100nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287999(US10087167, Compound 4008)
Affinity DataEC50:  107nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288009(US10087167, Compound 4018)
Affinity DataEC50:  550nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287985(US10087167, Compound 2001)
Affinity DataEC50:  550nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287997(US10087167, Compound 4006)
Affinity DataEC50:  550nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288010(US10087167, Compound 4019)
Affinity DataEC50: >1.00E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288018(US10087167, Compound 4027)
Affinity DataEC50: >1.00E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288012(US10087167, Compound 4021)
Affinity DataEC50: >1.00E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM288008(US10087167, Compound 4017)
Affinity DataEC50: >1.00E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287990(US10087167, Compound 4001)
Affinity DataEC50: >1.00E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM287994(US10087167, Compound 4004)
Affinity DataEC50:  1.69E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent